Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Laparoscopy | 24 | 2019 | 1532 | 3.15 | Why? |
| Pancreaticoduodenectomy | 4 | 2018 | 60 | 2.17 | Why? |
| Rectal Neoplasms | 3 | 2019 | 278 | 1.66 | Why? |
| Transanal Endoscopic Surgery | 2 | 2019 | 19 | 1.55 | Why? |
| Obesity, Morbid | 13 | 2021 | 1340 | 1.53 | Why? |
| Colorectal Neoplasms | 8 | 2019 | 1884 | 1.28 | Why? |
| Pancreatic Neoplasms | 3 | 2018 | 609 | 1.23 | Why? |
| Postoperative Complications | 20 | 2021 | 5861 | 1.20 | Why? |
| Gastric Bypass | 7 | 2018 | 152 | 1.18 | Why? |
| Bariatric Surgery | 10 | 2021 | 1298 | 1.10 | Why? |
| Minimally Invasive Surgical Procedures | 3 | 2017 | 663 | 1.01 | Why? |
| Surgical Wound Infection | 2 | 2018 | 501 | 0.96 | Why? |
| Splenectomy | 2 | 2019 | 85 | 0.92 | Why? |
| Adrenalectomy | 2 | 2018 | 32 | 0.90 | Why? |
| Gastrectomy | 8 | 2018 | 225 | 0.89 | Why? |
| Parenteral Nutrition, Home | 2 | 2018 | 68 | 0.86 | Why? |
| Bariatrics | 1 | 2020 | 57 | 0.84 | Why? |
| Appendectomy | 3 | 2019 | 585 | 0.79 | Why? |
| Nutritional Sciences | 1 | 2019 | 57 | 0.74 | Why? |
| Anal Canal | 2 | 2019 | 367 | 0.74 | Why? |
| Fat Emulsions, Intravenous | 1 | 2018 | 14 | 0.73 | Why? |
| Organ Sparing Treatments | 1 | 2018 | 91 | 0.73 | Why? |
| Pheochromocytoma | 1 | 2018 | 32 | 0.72 | Why? |
| Intestinal Diseases | 2 | 2018 | 231 | 0.71 | Why? |
| Mesenteric Artery, Superior | 1 | 2017 | 29 | 0.69 | Why? |
| Esophageal Neoplasms | 3 | 2017 | 357 | 0.66 | Why? |
| Reoperation | 3 | 2018 | 544 | 0.66 | Why? |
| Serum Amyloid A Protein | 1 | 2018 | 211 | 0.65 | Why? |
| Digestive System Surgical Procedures | 3 | 2018 | 677 | 0.64 | Why? |
| Operative Time | 7 | 2019 | 450 | 0.64 | Why? |
| Statistics as Topic | 1 | 2019 | 370 | 0.64 | Why? |
| Pancreatectomy | 1 | 2017 | 87 | 0.63 | Why? |
| Esophagus | 1 | 2017 | 139 | 0.58 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.58 | Why? |
| Poland | 12 | 2020 | 2368 | 0.56 | Why? |
| Colonic Neoplasms | 1 | 2019 | 295 | 0.56 | Why? |
| Appendicitis | 3 | 2019 | 946 | 0.56 | Why? |
| Ghrelin | 3 | 2018 | 22 | 0.54 | Why? |
| Serum Albumin | 1 | 2018 | 571 | 0.53 | Why? |
| Gastrointestinal Neoplasms | 1 | 2018 | 392 | 0.50 | Why? |
| Length of Stay | 11 | 2019 | 11042 | 0.47 | Why? |
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2019 | 645 | 0.42 | Why? |
| Ileostomy | 2 | 2019 | 45 | 0.39 | Why? |
| Ceruletide | 2 | 2017 | 4 | 0.36 | Why? |
| Sensory Receptor Cells | 2 | 2017 | 44 | 0.34 | Why? |
| Adrenal Gland Neoplasms | 2 | 2018 | 70 | 0.33 | Why? |
| Frailty | 1 | 2019 | 1432 | 0.32 | Why? |
| Stomach Neoplasms | 3 | 2017 | 477 | 0.32 | Why? |
| Statistics, Nonparametric | 3 | 2019 | 1008 | 0.32 | Why? |
| Pancreatitis | 3 | 2018 | 688 | 0.28 | Why? |
| Rectum | 2 | 2018 | 495 | 0.28 | Why? |
| Disease-Free Survival | 3 | 2018 | 1654 | 0.27 | Why? |
| Treatment Outcome | 15 | 2019 | 51732 | 0.27 | Why? |
| Postoperative Care | 3 | 2018 | 755 | 0.27 | Why? |
| Elective Surgical Procedures | 3 | 2020 | 5338 | 0.26 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2019 | 10649 | 0.26 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.24 | Why? |
| Bariatric Medicine | 1 | 2021 | 15 | 0.23 | Why? |
| Biomarkers | 4 | 2018 | 23361 | 0.21 | Why? |
| Neoplasm Recurrence, Local | 2 | 2018 | 1063 | 0.21 | Why? |
| Printing, Three-Dimensional | 2 | 2017 | 624 | 0.21 | Why? |
| Blood Loss, Surgical | 2 | 2018 | 211 | 0.20 | Why? |
| Wound Closure Techniques | 1 | 2019 | 18 | 0.20 | Why? |
| Pancreas | 3 | 2018 | 398 | 0.20 | Why? |
| Adenocarcinoma | 2 | 2018 | 651 | 0.20 | Why? |
| Recovery of Function | 3 | 2019 | 2461 | 0.19 | Why? |
| Fatty Acids, Essential | 1 | 2018 | 5 | 0.19 | Why? |
| Abdomen | 2 | 2019 | 424 | 0.19 | Why? |
| Omentum | 1 | 2018 | 23 | 0.19 | Why? |
| Perioperative Care | 3 | 2018 | 1329 | 0.19 | Why? |
| Humans | 56 | 2021 | 930598 | 0.18 | Why? |
| Anastomotic Leak | 1 | 2018 | 46 | 0.18 | Why? |
| Mesenteric Veins | 1 | 2018 | 60 | 0.18 | Why? |
| Olive Oil | 1 | 2018 | 46 | 0.18 | Why? |
| Feasibility Studies | 2 | 2018 | 3467 | 0.18 | Why? |
| Retroperitoneal Space | 1 | 2018 | 68 | 0.18 | Why? |
| Splenic Diseases | 1 | 2018 | 28 | 0.18 | Why? |
| Receptors, Ghrelin | 1 | 2017 | 1 | 0.18 | Why? |
| Uromodulin | 1 | 2017 | 5 | 0.18 | Why? |
| Capsaicin | 1 | 2017 | 19 | 0.18 | Why? |
| Acinar Cells | 1 | 2017 | 14 | 0.18 | Why? |
| Denosumab | 1 | 2017 | 49 | 0.17 | Why? |
| Bilirubin | 2 | 2018 | 503 | 0.17 | Why? |
| Middle Aged | 33 | 2020 | 270681 | 0.17 | Why? |
| Pancreatitis, Acute Necrotizing | 1 | 2017 | 47 | 0.17 | Why? |
| Choledocholithiasis | 1 | 2016 | 33 | 0.17 | Why? |
| Prognosis | 7 | 2019 | 32490 | 0.17 | Why? |
| Diverticulum | 1 | 2016 | 28 | 0.17 | Why? |
| Male | 36 | 2020 | 367725 | 0.16 | Why? |
| Intraabdominal Infections | 1 | 2017 | 90 | 0.16 | Why? |
| Female | 35 | 2020 | 380317 | 0.16 | Why? |
| Gastrointestinal Stromal Tumors | 1 | 2017 | 84 | 0.16 | Why? |
| Gallstones | 1 | 2016 | 64 | 0.16 | Why? |
| Bile Acids and Salts | 1 | 2017 | 91 | 0.16 | Why? |
| Esophagitis | 1 | 2016 | 21 | 0.16 | Why? |
| Esophagogastric Junction | 1 | 2015 | 30 | 0.15 | Why? |
| Prospective Studies | 8 | 2018 | 43301 | 0.15 | Why? |
| Bone Density Conservation Agents | 1 | 2017 | 209 | 0.15 | Why? |
| Weight Loss | 2 | 2018 | 826 | 0.15 | Why? |
| Colitis | 1 | 2018 | 266 | 0.14 | Why? |
| Barrett Esophagus | 1 | 2016 | 68 | 0.14 | Why? |
| Bone Density | 1 | 2017 | 335 | 0.14 | Why? |
| Forkhead Transcription Factors | 1 | 2016 | 231 | 0.14 | Why? |
| Follow-Up Studies | 5 | 2019 | 17020 | 0.13 | Why? |
| Syndrome | 1 | 2019 | 1310 | 0.13 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2016 | 237 | 0.13 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.13 | Why? |
| Hepatectomy | 1 | 2017 | 276 | 0.13 | Why? |
| Body Mass Index | 4 | 2019 | 4306 | 0.13 | Why? |
| Liver | 2 | 2018 | 4007 | 0.12 | Why? |
| Platelet Count | 1 | 2019 | 1381 | 0.12 | Why? |
| Aged | 18 | 2019 | 215776 | 0.12 | Why? |
| Adult | 27 | 2020 | 244371 | 0.12 | Why? |
| Preoperative Period | 3 | 2018 | 271 | 0.12 | Why? |
| Early Diagnosis | 2 | 2018 | 2443 | 0.12 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.11 | Why? |
| Patient Readmission | 2 | 2018 | 1543 | 0.11 | Why? |
| Colonoscopy | 1 | 2018 | 738 | 0.11 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.11 | Why? |
| Liver Function Tests | 1 | 2018 | 1325 | 0.11 | Why? |
| Retrospective Studies | 13 | 2019 | 105322 | 0.11 | Why? |
| Surgery Department, Hospital | 1 | 2020 | 954 | 0.11 | Why? |
| Multivariate Analysis | 2 | 2019 | 5440 | 0.11 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2018 | 2483 | 0.10 | Why? |
| Medical Staff, Hospital | 1 | 2020 | 1258 | 0.10 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2021 | 6166 | 0.10 | Why? |
| Logistic Models | 3 | 2019 | 9089 | 0.10 | Why? |
| Robotic Surgical Procedures | 1 | 2017 | 787 | 0.09 | Why? |
| Antimicrobial Stewardship | 1 | 2017 | 931 | 0.09 | Why? |
| Conversion to Open Surgery | 2 | 2018 | 35 | 0.09 | Why? |
| General Surgery | 2 | 2020 | 1472 | 0.09 | Why? |
| Nutritional Status | 1 | 2018 | 1403 | 0.09 | Why? |
| Multiple Organ Failure | 1 | 2018 | 1724 | 0.09 | Why? |
| Feeding Behavior | 1 | 2020 | 1909 | 0.09 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 907 | 0.09 | Why? |
| Cohort Studies | 7 | 2021 | 36005 | 0.09 | Why? |
| Life Style | 1 | 2020 | 2708 | 0.08 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.08 | Why? |
| Clinical Protocols | 1 | 2018 | 2734 | 0.08 | Why? |
| Surgeons | 1 | 2021 | 2233 | 0.08 | Why? |
| Internship and Residency | 2 | 2018 | 4987 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2018 | 1956 | 0.08 | Why? |
| Leukocytes, Mononuclear | 1 | 2016 | 2115 | 0.08 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.08 | Why? |
| Rats | 3 | 2018 | 2764 | 0.07 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.07 | Why? |
| Rats, Wistar | 2 | 2017 | 621 | 0.07 | Why? |
| Intraoperative Complications | 2 | 2018 | 221 | 0.07 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.07 | Why? |
| Postoperative Period | 2 | 2018 | 651 | 0.07 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1573 | 0.07 | Why? |
| Liver Neoplasms | 1 | 2017 | 1666 | 0.07 | Why? |
| Tertiary Care Centers | 2 | 2019 | 8248 | 0.07 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.06 | Why? |
| Age Factors | 3 | 2019 | 21039 | 0.06 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.06 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.06 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.06 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.06 | Why? |
| Education, Medical, Graduate | 1 | 2016 | 2082 | 0.06 | Why? |
| Sepsis | 1 | 2019 | 3517 | 0.06 | Why? |
| C-Reactive Protein | 1 | 2018 | 7972 | 0.06 | Why? |
| Risk Factors | 6 | 2019 | 71621 | 0.05 | Why? |
| Palliative Care | 1 | 2015 | 2665 | 0.05 | Why? |
| Interleukin-6 | 1 | 2018 | 7522 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Surgical Staplers | 1 | 2019 | 3 | 0.05 | Why? |
| Exercise | 1 | 2020 | 6771 | 0.05 | Why? |
| Trinitrobenzenesulfonic Acid | 1 | 2018 | 12 | 0.05 | Why? |
| Gastroplasty | 1 | 2018 | 20 | 0.05 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.05 | Why? |
| Injury Severity Score | 1 | 2019 | 287 | 0.05 | Why? |
| Surveys and Questionnaires | 3 | 2020 | 43792 | 0.05 | Why? |
| Secondary Care Centers | 1 | 2018 | 119 | 0.05 | Why? |
| Feedback, Physiological | 1 | 2017 | 56 | 0.04 | Why? |
| Peritoneum | 1 | 2017 | 54 | 0.04 | Why? |
| Stomach | 1 | 2018 | 141 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Absorptiometry, Photon | 1 | 2017 | 168 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.04 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2017 | 113 | 0.04 | Why? |
| Epirubicin | 1 | 2015 | 21 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2019 | 961 | 0.04 | Why? |
| Organoplatinum Compounds | 1 | 2015 | 76 | 0.04 | Why? |
| Leucovorin | 1 | 2015 | 70 | 0.04 | Why? |
| Models, Anatomic | 1 | 2017 | 191 | 0.04 | Why? |
| Intra-Abdominal Fat | 1 | 2018 | 227 | 0.04 | Why? |
| Hospitals, Special | 1 | 2020 | 523 | 0.04 | Why? |
| Capecitabine | 1 | 2015 | 51 | 0.04 | Why? |
| Learning Curve | 1 | 2016 | 157 | 0.04 | Why? |
| Interleukin-4 | 1 | 2017 | 367 | 0.04 | Why? |
| Young Adult | 4 | 2019 | 93724 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Kidney Function Tests | 1 | 2017 | 520 | 0.04 | Why? |
| Fluorouracil | 1 | 2015 | 169 | 0.04 | Why? |
| Hospitals, University | 2 | 2018 | 4173 | 0.03 | Why? |
| Acute Disease | 2 | 2018 | 6029 | 0.03 | Why? |
| Cisplatin | 1 | 2015 | 209 | 0.03 | Why? |
| Receptor, ErbB-2 | 1 | 2015 | 267 | 0.03 | Why? |
| Spleen | 1 | 2018 | 877 | 0.03 | Why? |
| Colon | 1 | 2018 | 669 | 0.03 | Why? |
| Luminescent Measurements | 1 | 2018 | 924 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2017 | 1262 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2017 | 1329 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.03 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2016 | 2275 | 0.02 | Why? |
| Critical Pathways | 1 | 2018 | 1587 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2015 | 4260 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Surgical Procedures, Operative | 1 | 2020 | 2662 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.02 | Why? |
| Animals | 3 | 2018 | 78931 | 0.02 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.02 | Why? |
| Immunoassay | 1 | 2018 | 4485 | 0.01 | Why? |
| Aged, 80 and over | 3 | 2018 | 88759 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.01 | Why? |
| Hospital Mortality | 1 | 2019 | 22087 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Time Factors | 1 | 2016 | 31397 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
Pedziwiatr's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(240)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(463)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_